Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen in the United States with an estimated 5 million cases annually. Studies have been in progress to define the clinical spectrum of chlamydial infection, to develop improved diagnostic assays and to examine the pathogenesis of chlamydial infection in experimental animal models. Chlamydia infections tend to have the characteristics of a prevalent infection since infection rates vary little by either sex, number of sex partners or the patient's relationship with their sexual partners. Chlamydial cervical infections in women were higher in contacts (26%) than in non-contacts (16%), particularly in contacts of men with gonorrhea (32%), suggesting that co-infection with N. gonorrhoeae and C. trachomatis are quite frequent in this population. Detection of chlamydia species by polymerase chain reaction (PCR) and genotyping by restriction enzyme analysis have been developed. In addition to differentiation of C. pneumoniae, C. trachomatis and C. psittaci, we have demonstrated that nearly three-quarters of C. trachomatis serovars are comprised of D, E and F. Serovar distribution did not correlate with clinical presentation, concurrent gonococcal infection or concordance among sexual couples. In a field study of trachoma in Tanzania, PCR detection of chlamydia genome was demonstrated to have a threefold increase in sensitivity compared to DFA, and a semi-quantitative PCR technique was utilized to monitor response to therapy in over 200 children with trachoma. In an experimental animal model where viability of C. trachomatis can be monitored, we demonstrated persistence of chlamydial DNA by PCR in monkeys who have become culture negative. This persistence of chlamydial DNA may possibly contribute to either a sustained hypersensitivity response or a latent state which is inhibited by the presence of neutralizing antibody and cell - mediated immunity. Finally, the 16s rRNA of C. pneumoniae was sequenced and compared to C. psittaci and C. trachomatis, demonstrating that C. pneumoniae is more closely related to C. psittaci than C. trachomatis. Additional studies utilizing primer sets from the 16s rRNA sequence are planned for PCR detection of C. pneumoniae as an etiologic agent of pneumonia in pediatric, adult and geriatric populations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000358-10
Application #
3803166
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Flannery, Erika L; McNamara, Case W; Kim, Sang Wan et al. (2015) Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. ACS Chem Biol 10:413-20
Summerton, Jean; Riedesel, Melissa; Laeyendecker, Oliver et al. (2007) Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics. Clin Vaccine Immunol 14:1545-9
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS 21 Suppl 2:S91-8
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS 21 Suppl 2:S81-90
NIMH Collaborative HIV/STD Prevention Trial Group (2007) The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS 21 Suppl 2:S59-68
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S69-80
NIMH Collaborative HIV/STD Prevention Trial (2007) Role of the data safety and monitoring board in an international trial. AIDS 21 Suppl 2:S99-102
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S29-36
West, Sheila K; Munoz, Beatriz; Mkocha, Harran et al. (2007) Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Invest Ophthalmol Vis Sci 48:1492-7
Rizzo-Price, Patricia; Stamper, Paul D; Wood, Billie Jo et al. (2007) Can nucleic acid amplification tests be used to test for chlamydia and gonorrhoea in microbicide trials? Int J STD AIDS 18:543-5

Showing the most recent 10 out of 84 publications